Literature DB >> 30596879

Rheumatoid Arthritis.

Jeffrey A Sparks1.   

Abstract

Rheumatoid arthritis (RA) is a common systemic inflammatory autoimmune disease characterized by painful, swollen joints that can severely impair physical function and quality of life. The presenting symptoms of musculoskeletal pain, swelling, and stiffness are common in clinical practice, so familiarity with diagnosing and managing RA is crucial. Patients with RA are at greater risk for serious infection, respiratory disease, osteoporosis, cardiovascular disease, cancer, and mortality than the general population. In recent years, early diagnosis, aggressive treatment, and expanded therapeutic options of disease-modifying antirheumatic drugs have markedly improved both the management and long-term prognosis of RA.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30596879     DOI: 10.7326/AITC201901010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  125 in total

1.  Role of RP11-83J16.1, a novel long non-coding RNA, in rheumatoid arthritis.

Authors:  Xuemei Piao; Jieru Zhou; Jiandong Hu
Journal:  Am J Transl Res       Date:  2020-04-15       Impact factor: 4.060

Review 2.  Obstructive lung diseases and risk of rheumatoid arthritis.

Authors:  H Maura Friedlander; Julia A Ford; Alessandra Zaccardelli; Alexsandra V Terrio; Michael H Cho; Jeffrey A Sparks
Journal:  Expert Rev Clin Immunol       Date:  2020-01-06       Impact factor: 4.473

3.  LncRNA LOC100912373 modulates PDK1 expression by sponging miR-17-5p to promote the proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Chang Fan; Xiaoya Cui; Sen Chen; Shaopeng Huang; Hui Jiang
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 4.  Potential role of mitochondria in synoviocytes.

Authors:  Muzhe Li; Xuling Luo; Xin Long; Peishi Jiang; Qin Jiang; Heng Guo; Zhiwei Chen
Journal:  Clin Rheumatol       Date:  2020-07-01       Impact factor: 2.980

5.  Effect of combined application of iguratimod in the treatment of active rheumatoid arthritis on bone metabolism, Th17 cells and Treg cells.

Authors:  Li Wen; Wei Jiang; Meiqun Zhou; Zhenxia Wu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

6.  The risk of leukemia in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Xiao Luo; Yue He; Wangdong Xu; Mao Liu; Zixia Zhao; Lihui Peng; Chengsong He; Jie Chen
Journal:  Clin Rheumatol       Date:  2020-09-17       Impact factor: 2.980

7.  Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality.

Authors:  Sicong Huang; Tracy J Doyle; Mark M Hammer; Suzanne C Byrne; Weixing Huang; Allison A Marshall; Christine K Iannaccone; Jie Huang; Vivi Feathers; Michael E Weinblatt; Paul F Dellaripa; Nancy A Shadick; Jeffrey A Sparks
Journal:  Semin Arthritis Rheum       Date:  2020-09-28       Impact factor: 5.532

8.  Soufeng sanjie formula alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation.

Authors:  Di Hua; Jie Yang; Qinghai Meng; Yuanyuan Ling; Qin Wei; Zhigang Wang; Qingyun Wei; Jiao Chen; Juan Ye; Xuan Han; Kelei Su; Weikang Kong; Chao Xu; Peng Cao; Chunping Hu
Journal:  Chin Med       Date:  2021-05-13       Impact factor: 5.455

9.  Lentivirus-Mediated Overexpression or Silencing of Aquaporin 1 Affects the Proliferation, Migration and Invasion of TNF-α-Stimulated Rheumatoid Arthritis Fibroblast-Like Synoviocytes by Wnt/β-Catenin Signaling Pathway.

Authors:  Meng-Yuan Zhou; Li Cai; Xiao-Wen Feng; Yu-Rong Mu; Bo Meng; Fang-Yuan Liu; Rong Li
Journal:  J Inflamm Res       Date:  2021-05-14

10.  miR-483-3p Promotes IL-33 Production from Fibroblast-Like Synoviocytes by Regulating ERK Signaling in Rheumatoid Arthritis.

Authors:  Kailin Zhang; WenYi Fu; Shuai Zhao; Ting Jiao; Dan Wu; YueJiao Wang
Journal:  Inflammation       Date:  2021-06-23       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.